{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:29Z","timestamp":1792737689520,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471460"],"award-info":[{"award-number":["82471460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101417"],"award-info":[{"award-number":["82101417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["ZKX22025"],"award-info":[{"award-number":["ZKX22025"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231120"],"award-info":[{"award-number":["BK20231120"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jep.2026.122293","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:42:58Z","timestamp":1786722178000},"page":"122293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel natural inhibitor Rubimaillin targets NLRP3 R167\/Y381 to ameliorate inflammatory and neurodegenerative diseases"],"prefix":"10.1016","volume":"373","author":[{"given":"Jing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuobin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Lin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jep.2026.122293_bib1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.jep.2026.122293_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay between NLRP3 inflammasome and autophagy","volume":"11","author":"Biasizzo","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jep.2026.122293_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jep.2026.122293_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jep.2026.122293_bib5","article-title":"Gastrodenol suppresses NLRP3\/GSDMD mediated pyroptosis and ameliorates inflammatory diseases","volume":"405\u2013406","author":"Chen","year":"2024","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.jep.2026.122293_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101069","article-title":"New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3","volume":"15","author":"Chen","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jep.2026.122293_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jep.2017.11.005","article-title":"Anti-thrombotic and pro-angiogenic effects of Rubia cordifolia extract in zebrafish","volume":"219","author":"Chen","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.jep.2026.122293_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2026.122293_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115107","article-title":"Label-free target protein characterization for small molecule drugs: recent advances in methods and applications","volume":"223","author":"Feng","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jep.2026.122293_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1176448","article-title":"A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +\/- RRx-001 in newly diagnosed glioblastoma","volume":"13","author":"Fine","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jep.2026.122293_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.jep.2026.122293_bib12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00011-023-01790-4","article-title":"Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases","volume":"72","author":"Han","year":"2023","journal-title":"Inflamm. Res."},{"issue":"7590","key":"10.1016\/j.jep.2026.122293_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jep.2026.122293_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23082030","article-title":"CF3-Substituted mollugin 2-(4-Morpholinyl)-ethyl ester as a potential anti-inflammatory agent with improved aqueous solubility and metabolic stability","volume":"23","author":"Hong","year":"2018","journal-title":"Molecules"},{"issue":"0","key":"10.1016\/j.jep.2026.122293_bib15","article-title":"Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases","volume":"156","author":"Huaiping","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.jep.2026.122293_bib16","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jep.2026.122293_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bioorg.2013.11.008","article-title":"Synthesis of novel and diverse mollugin analogues and their antibacterial and antioxidant activities","volume":"52","author":"Idhayadhulla","year":"2014","journal-title":"Bioorg. Chem."},{"issue":"4\u20135","key":"10.1016\/j.jep.2026.122293_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10863-025-10063-0","article-title":"Mollugin attenuates oxygen-glucose deprivation\/reperfusion-induced brain microvascular endothelial cell death and permeability through activation of BDNF\/TrkB-modulated Akt pathway","volume":"57","author":"Jia","year":"2025","journal-title":"J. Bioenerg. Biomembr."},{"issue":"12","key":"10.1016\/j.jep.2026.122293_bib19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41418-024-01367-6","article-title":"Gelsolin alleviates rheumatoid arthritis by negatively regulating NLRP3 inflammasome activation","volume":"31","author":"Lee","year":"2024","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.jep.2026.122293_bib20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s11596-020-2262-5","article-title":"Anti-inflammatory activity of mollugin on DSS-induced colitis in mice","volume":"40","author":"Li","year":"2020","journal-title":"Curr Med Sci"},{"issue":"3","key":"10.1016\/j.jep.2026.122293_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/10799893.2020.1808675","article-title":"Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-\u03baB signaling","volume":"41","author":"Li","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"10","key":"10.1016\/j.jep.2026.122293_bib22","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1080\/15548627.2023.2213984","article-title":"Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment","volume":"19","author":"Li","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.jep.2026.122293_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175630","article-title":"Mollugin ameliorates murine allergic airway inflammation by inhibiting Th2 response and M2 macrophage activation","volume":"946","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2026.122293_bib24","article-title":"The regulation and modification of GSDMD signaling in diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jep.2026.122293_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s43556-025-00363-7","article-title":"ML345 is a potent and selective NLRP3 inflammasome inhibitor with anti-inflammatory activity","volume":"6","author":"Lin","year":"2025","journal-title":"Mol Biomed"},{"key":"10.1016\/j.jep.2026.122293_bib26","article-title":"Role of NLRP3 in the pathogenesis and treatment of gout arthritis","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jep.2026.122293_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109941","article-title":"NLRP3 inflammasome signalling in Alzheimer's disease","volume":"252","author":"McManus","year":"2024","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.jep.2026.122293_bib28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41423-023-01107-9","article-title":"Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis","volume":"20","author":"Oh","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jep.2026.122293_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105710","article-title":"Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"170","author":"\u00d6zenver","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2026.122293_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug affinity responsive target stability (DARTS) for small-molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.jep.2026.122293_bib31","article-title":"New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3","volume":"15","author":"Peipei","year":"2025","journal-title":"J. Pharm. Anal."},{"issue":"0","key":"10.1016\/j.jep.2026.122293_bib32","article-title":"High-Throughput screening reveals that CeeNU acts as a new NLRP3 inflammasome inhibitor","volume":"7","author":"Sen-Lin","year":"2026","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.jep.2026.122293_bib33","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12153","article-title":"NLRP3 inflammasome in sepsis","volume":"24","author":"Shi","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.jep.2026.122293_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jep.2026.122293_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114687","article-title":"Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases","volume":"156","author":"Tang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jep.2026.122293_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.965390","article-title":"A comprehensive review of Rubia cordifolia L.: traditional uses, phytochemistry, pharmacological activities, and clinical applications","volume":"13","author":"Wen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.jep.2026.122293_bib37","article-title":"Identification of anti-inflammatory and anti-cancer compounds targeting the NF-\u03baB-NLRP3 inflammasome pathway from a phytochemical library of the Sideritis genus","volume":"338","author":"Y\u00fccer","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.122293_bib38","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.jep.2026.122293_bib39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41423-022-00891-0","article-title":"Dextran sodium sulfate potentiates NLRP3 inflammasome activation by modulating the KCa3.1 potassium channel in a mouse model of colitis","volume":"19","author":"Zeng","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jep.2026.122293_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/DDDT.S388932","article-title":"The underlying mechanisms exploration of Rubia cordifolia L. extract against rheumatoid arthritis by integrating network pharmacology and metabolomics","volume":"17","author":"Zeng","year":"2023","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126011487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126011487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:35:27Z","timestamp":1792737327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126011487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":40,"alternative-id":["S0378874126011487"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.122293","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel natural inhibitor Rubimaillin targets NLRP3 R167\/Y381 to ameliorate inflammatory and neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.122293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122293"}}